Aristotle Capital Boston’s Healthpeak Properties DOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.32M Sell
108,350
-35,260
-25% -$658K 0.16% 107
2026
Q1
$2.37M Sell
143,610
-418
-0.3% -$7.16K 0.15% 109
2025
Q4
$2.32M Sell
144,028
-14,501
-9% -$256K 0.13% 110
2025
Q3
$3.04M Buy
158,529
+22,967
+17% +$412K 0.16% 108
2025
Q2
$2.37M Sell
135,562
-4,020
-3% -$71.4K 0.12% 112
2025
Q1
$2.82M Sell
139,582
-12,096
-8% -$245K 0.14% 112
2024
Q4
$3.07M Buy
+151,678
New +$3.29M 0.11% 121

Other funds holding DOC

Aristotle Capital Boston's DOC Position: Q2 2026 in Review

Aristotle Capital Boston reduced its Healthpeak Properties (DOC) stake by 25% in Q2 2026, selling an estimated $658K and leaving 108,350 shares worth $2.32M. The position accounts for 0.16% of the portfolio, ranked #107.

Aristotle Capital Boston first reported a position in DOC in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.07M in Q4 2024. 757 funds tracked by Wall St. Rank hold DOC as of Q2 2026.

  • Aristotle Capital Boston held 108,350 shares of Healthpeak Properties worth $2.32M as of Q2 2026.
  • Aristotle Capital Boston sold 35,260 Healthpeak Properties shares in Q2 2026, an estimated $658K.
  • Healthpeak Properties made up 0.16% of Aristotle Capital Boston's portfolio in Q2 2026, its #107 holding.
  • Aristotle Capital Boston first reported a position in Healthpeak Properties in Q4 2024 and has held it in 7 quarters since.
  • Aristotle Capital Boston's Healthpeak Properties position peaked at $3.07M in Q4 2024.
  • 757 funds tracked by Wall St. Rank held Healthpeak Properties as of Q2 2026.

Based on Aristotle Capital Boston's 13F filing for Q2 2026, filed 14 Aug 2026.